Department of Obstetrics and Gynaecology

Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer – results from the phase II DETECT IVb trial (2026) Schochter F, Friedl TW, Schäffler H, Meier-Stiegen F, Pfister KN, Riethdorf S, Wiesmüller L, et al. Journal article AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer—2026 Update (2026) Hartkopf A, Albert US, Bartsch R, Bauerfeind I, Banys-Paluchowski M, Bjelic-Radisic V, Blohmer JU, et al. Journal article, Review article Breast MRI With Abbreviated Reading Protocol as Additional Evaluation Tool for Suspicious Microcalcifications in a Screening Cohort: Diagnostic Performance and Interreader Agreement (2026) Pöschke P, Wenkel E, Schulmeyer C, Hack CC, Beckmann MW, Janka RM, Brehm B, et al. Journal article Professional Health Literacy among Midwives - Findings from a Standardised Online Survey Conducted in Bavaria Professionelle Gesundheitskompetenz von Hebammen - Ergebnisse einer standardisierten Online-Befragung in Bayern (2026) Sponsel S, Pfaller L, Karrer L, Schöffski O, Beckmann M, Mocker A Journal article Diagnostik und Therapie der Endometriose (2026) Fehm TN, Burghaus S, Schäfer SD, Ulrich UA Journal article The Role of Large Language Models in Hormonal Contraception Consultation (2026) Psilopatis I, Emons J, Zwimpfer TA Journal article Real-world insights into bone marrow carcinomatosis in metastatic breast cancer: a retrospective analysis from two large university breast cancer centers (2026) Tauber N, Neubacher M, Amann N, P. Cieslik J, Esposito I, Fick F, Freier C, et al. Journal article Breast cancer prevention in patients with gBRCA-mutated ovarian cancer (2026) Amann N, Krückel A, Brückner L, Gocke J, Müller C, Heindl F, Hack C, et al. Journal article Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for high-risk early-stage TNBC: Final analysis results from the phase 3 KEYNOTE-522 study. (2026) Schmid P, Cortes J, Dent RA, McArthur HL, Pusztai L, Kuemmel S, Denkert C, et al. Journal article The SURVIVE study: Re-evaluating follow-up in early breast cancer. (2026) Huesmann ST, Friedl TW, Pfister K, Schäffler H, Fink A, Braun T, Mehmeti F, et al. Journal article